06
Список
литературы
Российское общество дерматовенерологов и косметологов, Российская ассоциация аллергологов и клинических иммунологов. Клинические рекомендации "Атопический дерматит" (утв. Министерством здравоохранения Российской Федерации 27 июня 2024 г.) // МЗ РФ. — Москва: 2024. https://base.garant.ru/410443713/
American Academy of Dermatology (AAD). Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies // Journal of the American Academy of Dermatology. — 2023. https://www.aad.org/member/clinical-quality/guidelines/atopic-dermatitis
Japanese Dermatological Association (JDA), Japanese Society of Allergology (JSA). English version of clinical practice guidelines for the management of atopic dermatitis 2024 // The Journal of Dermatology. — 2025. https://onlinelibrary.wiley.com/doi/10.1111/1346-8138.17544
National Institute for Health and Care Excellence (NICE). Technology Appraisal 814: Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis // NICE. — Август 2022. https://www.nice.org.uk/guidance/ta814/resources/abrocitinib-tralokinumab-or-upadacitinib-for-treating-moderate-to-severe-atopic-dermatitis-pdf-82613310355141
Lax S., Santer M., Thomas KS., et al. Topical Anti-Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta-Analysis // Clinical & Experimental Allergy. — 2024; 54:960–972. https://eprints.soton.ac.uk/496955/1/Clin_Experimental_Allergy_-_2024_-_Lax_-_Topical_Anti_Inflammatory_Treatments_for_Eczema_A_Cochrane_Systematic_Review_and.pdf
Santer M., Ridd MJ., Harvey J., et al. Atopic eczema in primary care: evidence update and implications for practice // British Journal of General Practice. — 2024; 74(738): 40-42. DOI: https://doi.org/10.3399/bjgp24X736101. https://bjgp.org/content/74/738/40
Справочник MSD Профессиональная версия. Атопический дерматит (экзема) // Merck & Co., Inc. — Обновлено сентябрь 2025. https://www.msdmanuals.com/ru/professional/%D0%B4%D0%B5%D1%80%D0%BC%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F-%D0%BF%D0%B0%D1%82%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F/%D0%B4%D0%B5%D1%80%D0%BC%D0%B0%D1%82%D0%B8%D1%82/%D0%B0%D1%82%D0%BE%D0%BF%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9-%D0%B4%D0%B5%D1%80%D0%BC%D0%B0%D1%82%D0%B8%D1%82-%D1%8D%D0%BA%D0%B7%D0%B5%D0%BC%D0%B0